INSIGHT: Understanding Japan’s New ‘Sakigake’ Process
This article was originally published in PharmAsia News
Executive Summary
Japan's just introduced 'Sakigake' system is generating interest as a way to encourage the early development of novel therapies in the country, akin to the breakthrough therapy initiative in the U.S. One stakeholder helps explain the practicalities of the new scheme.